首页> 外文OA文献 >Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE)
【2h】

Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE)

机译:心力衰竭并发急性冠状动脉综合征的决定因素和预后影响:来自全球急性冠状动脉事件登记处(GRaCE)的观察

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUND: Few data are available on the impact of heart failure (HF) across all types of acute coronary syndromes (ACS).METHODS AND RESULTS: The Global Registry of Acute Coronary Events (GRACE) is a prospective study of patients hospitalized with ACS. Data from 16 166 patients were analyzed: 13 707 patients without prior HF or cardiogenic shock at presentation were identified. Of these, 1778 (13%) had an admission diagnosis of HF (Killip class II or III). HF on admission was associated with a marked increase in mortality rates during hospitalization (12.0% versus 2.9% [with versus without HF], P\u3c0.0001) and at 6 months after discharge (8.5% versus 2.8%, P\u3c0.0001). Of note, HF increased mortality rates in patients with unstable angina (defined as ACS with normal biochemical markers of necrosis; mortality rates: 6.7% with versus 1.6% without HF at admission, P\u3c0.0001). By logistic regression analysis, admission HF was an independent predictor of hospital death (odds ratio, 2.2; P\u3c0.0001). Admission HF was associated with longer hospital stay and higher readmission rates. Patients with HF had lower rates of catheterization and percutaneous cardiac intervention, and fewer received beta-blockers and statins. Hospital development of HF (versus HF on presentation) was associated with an even higher in-hospital mortality rate (17.8% versus 12.0%, P\u3c0.0001). In patients with HF, in-hospital revascularization was associated with lower 6-month death rates (14.0% versus 23.7%, P\u3c0.0001; adjusted hazard ratio, 0.5; 95% CI, 0.37 to 0.68, P\u3c0.0001).CONCLUSIONS: In this observational registry, heart failure was associated with reduced hospital and 6-month survival across all ACS subsets, including patients with normal markers of necrosis. More aggressive treatment of these patients may be warranted to improve prognosis.
机译:背景:关于心力衰竭(HF)对所有类型的急性冠脉综合征(ACS)的影响的数据很少。方法和结果:急性冠脉事件全球登记表(GRACE)是对ACS住院患者进行的前瞻性研究。分析了来自16 166例患者的数据:确定了13 707例既往无心衰或心源性休克的患者。其中,有1778名(13%)患有HF(吉利普II或III级)。入院时HF与住院期间死亡率显着增加(分别为12.0%和2.9%[有或无HF],P \ u3c0.0001)和出院后6个月时的死亡率(8.5%对2.8%,P \ u3c0)相关。 0001)。值得注意的是,HF增加了不稳定型心绞痛患者的死亡率(定义为具有正常坏死生化指标的ACS;死亡率:入院时为6.7%,无HF为1.6%,P \ u3c0.0001)。通过逻辑回归分析,入院HF是医院死亡的独立预测因子(优势比为2.2; P \ u3c0.0001)。入院HF与住院时间较长和再入院率较高有关。 HF患者的导管插入率和经皮心脏干预率较低,接受β受体阻滞剂和他汀类药物的患者较少。 HF的医院发展(相对于HF),院内死亡率更高(17.8%对12.0%,P \ u3c0.0001)。 HF患者的院内血运重建与较低的6个月死亡率相关(P \ u3c0.0001,14.0%vs 23.7%;调整后的危险比,0.5; 95%CI,0.37至0.68,P \ u3c0.0001结论:在该观察性登记中,心衰与所有ACS亚群(包括具有坏死标记正常的患者)的住院时间缩短和6个月生存率相关。可能需要对这些患者进行更积极的治疗以改善预后。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号